AngioDynamics
ANGO
167 hedge funds and large institutions have $731M invested in AngioDynamics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 25 closing their positions.
0.93% more ownership
Funds ownership: 98.79% → 99.72% (+0.93%)
0% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 59
7% less funds holding
Funds holding: 179 → 167 (-12)
13% less capital invested
Capital invested by funds: $839M → $731M (-$108M)
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$22.1M |
| 2 |
Millennium Management
New York
|
+$7.31M |
| 3 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$6.62M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$5.03M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$4.49M |
| 2 |
Man Group
London,
United Kingdom
|
-$4.41M |
| 3 |
JP Morgan Chase
New York
|
-$4.23M |
| 4 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$3.34M |
| 5 |
Renaissance Technologies
New York
|
-$2.33M |
ANGO Hedge Fund Activity: Q2 2019 in Review
167 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2019, worth a combined $731M — down 13% from $839M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ANGO and 17 opened new positions — a net loss of 8 holders — while 59 trimmed existing stakes and 59 added.
The largest buyer was Victory Capital Management, adding an estimated $22.1M. The largest seller was Segall Bryant & Hamill, cutting an estimated $4.49M.
- 167 institutional investors held AngioDynamics (ANGO) as of Q2 2019, down from 179 in Q1 2019.
- Funds reported $731M of AngioDynamics stock for Q2 2019, down 13% quarter-over-quarter.
- 17 funds opened new AngioDynamics positions in Q2 2019 and 25 closed out, a net change of -8 holders.
- The largest AngioDynamics buyer in Q2 2019 was Victory Capital Management, an estimated $22.1M added.
- The largest AngioDynamics seller in Q2 2019 was Segall Bryant & Hamill, an estimated $4.49M sold.
Based on aggregated 13F filings for Q2 2019.